Astrazeneca Pharma India Ltd
NSE:ASTRAZEN

Watchlist Manager
Astrazeneca Pharma India Ltd Logo
Astrazeneca Pharma India Ltd
NSE:ASTRAZEN
Watchlist
Price: 8 879 INR -3.15% Market Closed
Market Cap: 222B INR

Wall Street
Price Targets

ASTRAZEN Price Targets Summary
Astrazeneca Pharma India Ltd

There are no price targets for ASTRAZEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Astrazeneca Pharma India Ltd Competitors:
Price Targets
688185
CanSino Biologics Inc
9% Upside
NEULANDLAB
Neuland Laboratories Ltd
45% Upside
4521
Kaken Pharmaceutical Co Ltd
11% Upside
GRANULES
Granules India Ltd
1% Upside
SUPN
Supernus Pharmaceuticals Inc
21% Upside

Revenue
Forecast

Revenue Estimate
Astrazeneca Pharma India Ltd

For the last 13 years the compound annual growth rate for Astrazeneca Pharma India Ltd's revenue is 9%. The projected CAGR for the next 5 years is -13%.

9%
Past Growth
-13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Astrazeneca Pharma India Ltd

For the last 13 years the compound annual growth rate for Astrazeneca Pharma India Ltd's operating income is 19%. The projected CAGR for the next 5 years is -6%.

19%
Past Growth
-6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Astrazeneca Pharma India Ltd

For the last 13 years the compound annual growth rate for Astrazeneca Pharma India Ltd's net income is 15%. The projected CAGR for the next 5 years is -6%.

15%
Past Growth
-6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ASTRAZEN's stock price target?
Not Available

ASTRAZEN doesn't have any price targets made by Wall Street professionals.

What is Astrazeneca Pharma India Ltd's Revenue forecast?
Projected CAGR
-13%

For the last 13 years the compound annual growth rate for Astrazeneca Pharma India Ltd's revenue is 9%. The projected CAGR for the next 5 years is -13%.

What is Astrazeneca Pharma India Ltd's Operating Income forecast?
Projected CAGR
-6%

For the last 13 years the compound annual growth rate for Astrazeneca Pharma India Ltd's operating income is 19%. The projected CAGR for the next 5 years is -6%.

What is Astrazeneca Pharma India Ltd's Net Income forecast?
Projected CAGR
-6%

For the last 13 years the compound annual growth rate for Astrazeneca Pharma India Ltd's net income is 15%. The projected CAGR for the next 5 years is -6%.

Back to Top